Start Date
May 31, 2010
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
GSK's candidate influenza vaccine 1562902A
Intramuscular dose on Day 0 and Day 21
FluarixTM
Intramuscular dose on Day 42 or on Day -30, according to the vaccination schedule
Placebo
Intramuscular dose on Day 42 or on Day -30, according to the vaccination schedule
GSK Investigational Site, Curitiba/Paraná
Lead Sponsor
GlaxoSmithKline
INDUSTRY